|
1）Patterson D, Slack J. Lipid abnormalities in male and female survivors of myocardial infarction and their first-degree relatives. Lancet, 1972; 1: 393-9
|
|
|
|
2）Mabuchi H, Haba T, Ueda K, et al. Serum lipids and coronary heart disease in heterozygous familial hypercholesterolemia in the Hokuriku District of Japan. Atherosclerosis, 1977; 28: 417-23
|
|
|
|
|
3）Heiberg A, Berg K. The inheritance of hyper-lipoproteinaemia with xanthomatosis. A study of 132 kindreds. Clin Genet, 1976; 9: 203-33
|
|
|
|
|
|
4）Andersen GE, Lous P, Friis-Hansen B. Screening for hyperlipoproteinemia in 10,000 Danish newborns. Follow-up studies in 522 children with elevated cord serum VLDL-LDL-cholesterol. Acta Paediatr Scand. 1979; 68: 541-5
|
|
|
|
|
|
5）Kalina A, Csaszar A, Czeizel AE, et al. Frequency of the R3500Q mutation of the apolipoprotein B-100 gene in a sample screened clinically for familial hypercholesterolemia in Hungary. Atherosclerosis. 2001; 154: 247-51
|
|
|
|
|
|
6）Mabuchi H, Nohara A, Noguchi T, et al. Molecular genetic epidemiology of homozygous familial hypercholesterolemia in the Hokuriku district of Japan. Atherosclerosis. 2011; 214: 404-7
|
|
|
|
|
|
7）多田紀夫，吉田 博，寺本民生，他．我が国における高脂血症治療の実態調査（調査１高LDL-C血症患者と家族性高コレステロール血症患者における合併症，ならびに選択薬物の調査）-LiMAP1-. 第37回日本動脈硬化学会総会．2005
|
|
|
|
|
|
8）Leigh SE, Foster AH, Whittall RA, et al. Update and analysis of the University College London low density lipoprotein receptor familial hyper-cholesterolemia database. Ann Hum Genet. 2008; 72: 485-98
|
|
|
|
|
|
9）Goldstein JL HH, Brown MS. Familial hypercholesterolemia. Edited by Scriver CR BA, Sly WS, Valle D. New York: McGraw-Hill; 2001. p.2863-913
|
|
|
|
|
|
10）Liyanage KE, Burnett JR, Hooper AJ, et al. Familial hypercholesterolemia: epidemiology, Neolithic origins and modern geographic distribution. Crit Rev Clin Lab Sci. 2011; 48: 1-18
|
|
|
|
|
|
11）Abifadel M, Varret M, Rabes JP, et al. Mutations in PCSK9 cause autosomal dominant hyper-cholesterolemia. Nat Genet. 2003; 34: 154-6
|
|
|
|
|
|
12）Leigh SE, Leren TP, Humphries SE. Commentary PCSK9 variants: A new database. Athero-sclerosis. 2009; 203: 32-3
|
|
|
|
|
|
13）Garcia CK, Wilund K, Arca M, et al. Autosomal recessive hypercholesterolemia caused by mutations in a putative LDL receptor adaptor protein. Science. 2001; 292: 1394-8
|
|
|
|
|
|
14）Harada-Shiba M, Tajima S, Miyake Y, et al. Analysis of hypercholesterolemia with family history and normal LDL receptor. J Atheroscler Thromb. 1991; 19: 227-42
|
|
|
|
|
15）Harada-Shiba M, Tajima S, Yokoyama S, et al. Siblings with normal LDL receptor activity and severe hypercholesterolemia. Arterioscler Thromb. 1992; 12: 1071-8
|
|
|
|
|
|
16）Harada-Shiba M, Takagi A, Miyamoto Y, et al. Clinical features and genetic analysis of autosomal recessive hypercholesterolemia. J Clin Endocrinol Metab. 2003; 88: 2541-7
|
|
|
|
|
|
17）Tada H, Kawashiri MA, Ikewaki K, et al. Altered metabolism of low-density lipoprotein and very-low-density lipoprotein remnant in autosomal recessive hypercholesterolemia: results from stable isotope kinetic study in vivo. Circ Cardiovasc Genet. 2012; 5: 35-41
|
|
|
|
|
|
18）Arca M, Zuliani G, Wilund K, et al. Autosomal recessive hypercholesterolaemia in Sardinia, Italy, and mutations in ARH: a clinical and molecular genetic analysis. Lancet. 2002; 359: 841-7
|
|
|
|
|
|
19）Filigheddu F, Quagliarini F, Campagna F, et al. Prevalence and clinical features of heterozygous carriers of autosomal recessive hypercholesterol-emia in Sardinia. Atherosclerosis. 2009; 207: 162-7
|
|
|
|
|
|
20）Harada K, Miyamoto Y, Morisaki H, et al. A novel Thr56Met mutation of the autosomal recessive hypercholesterolemia gene associated with hypercholesterolemia. J Atheroscler Thromb. 2010; 17: 131-40
|
|
|
|
|
21）Yamamoto T, Harada-Shiba M, Nakatani M, et al. Cholesterol-lowering action of BNA-based antisense oligonucleotides targeting PCSK9 in atherogenic diet-induced hypercholesterolemic mice. Mol Ther Nucleic Acids. 2012; 1: e22
|
|
|
|
|